The Impact of Innovative Tax Proposals on Purchase Patterns

NACompletedINTERVENTIONAL
Enrollment

285

Participants

Timeline

Start Date

April 11, 2023

Primary Completion Date

May 27, 2025

Study Completion Date

June 10, 2025

Conditions
Cigarette Smoking
Interventions
BEHAVIORAL

Market Price Condition (control)

Nicotine/tobacco products available in the Experimental Tobacco Marketplace at market price. Cigarette taxes increased across trials at the same magnitudes used in the tax conditions.

BEHAVIORAL

Tobacco Parity Tax Condition

Tobacco products in the Experimental Tobacco Marketplace are placed into three tax tiers: high-, medium-, and no-tax. In this condition, all tobacco products are placed in the high-tax tier while products that do not contain tobacco (e.g., herbal cigarettes and nicotine-free ENDS) are placed in the medium-tax tier. Nicotine Replacement Therapy products are placed in the no-tax tier.

BEHAVIORAL

Nicotine-Content Tax Condition

Tobacco products in the Experimental Tobacco Marketplace are placed into three tax tiers: high-, medium-, and no-tax. In this condition, products with greater than 3 mg nicotine per single unit are placed in the high-tax tier, products with 0.6-3.0 mg/unit in the medium-tax tier, and those with 0.5 mg/unit or less in the no-tax tier.

BEHAVIORAL

Harm-Reduction Tax Condition

Tobacco products in the Experimental Tobacco Marketplace are placed into three tax tiers: high-, medium-, and no-tax. In this condition, all combustible products with high abuse liability are placed in the high-tax tier. All non-combustible products or combustible products with low abuse liability are placed in the medium-tax tier. Nicotine Replacement Therapy products are placed in the no-tax tier.

BEHAVIORAL

Modified Risk Tobacco Product (MRTP) Tax Condition

Tobacco products in the Experimental Tobacco Marketplace are placed into three tax tiers: high-, medium-, and no-tax. In this condition, all non-MRTP tobacco products are placed in the high-tax tier, MRTPs are placed in the medium-tax tier, and Nicotine Replacement Therapy products are placed in the no-tax tier.

Trial Locations (2)

14263

Roswell Park Comprehensive Cancer Center, Buffalo

24016

Fralin Biomedical Research Institute, Roanoke

All Listed Sponsors
collaborator

Roswell Park Cancer Institute

OTHER

lead

Virginia Polytechnic Institute and State University

OTHER